Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
ATP-sensitive K+ channel activator, α-adrenerg...
MAO and histone demethylase LSD1 inhibitor.
Endogenous amino acid, also found in meat, dair...
Insect growth regulator; chitin synthesis inhib...
Synthetic progestogen; PR agonist.
p110γ PI3K inhibitor.
RXR agonist.
Furanolactone found in Citrus.
Phytohormone
principal metabolic product of COX-2
Trichothecene mycotoxin produced by Fusarium.
Mycotoxin produced by Aspergillus; BK K+ channe...
Endogenous peptide, involved in vascular contra...
Anthraquinone found in Rheum.
Thienylbutyl ITC analog.
STING agonist
Building block
Dihydropyridine; L-type Ca2+ channel blocker.
Mycotoxin that has structural similarity to est...
L-type Ca2+ channel blocker.